| Effect of vaccinations and school restrictions on the spread of COVID-19 in different age groups in Germany C Dings, D Selzer, NL Bragazzi, E Möhler, M Wenning, T Gehrke, ... Infectious Disease Modelling 9 (4), 1250-1264, 2024 | | 2024 |
| Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug–drug interaction predictions HLH Loer, C Kovar, S Rüdesheim, FZ Marok, LM Fuhr, D Selzer, ... CPT: Pharmacometrics & Systems Pharmacology 13 (6), 926-940, 2024 | 1 | 2024 |
| Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy FZ Marok, JG Wojtyniak, D Selzer, R Dallmann, JJ Swen, HJ Guchelaar, ... Clinical Pharmacology & Therapeutics 115 (6), 1282-1292, 2024 | 1 | 2024 |
| A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug–drug interactions C Kovar, HLH Loer, S Rüdesheim, LM Fuhr, FZ Marok, D Selzer, ... CPT: Pharmacometrics & Systems Pharmacology, 2024 | | 2024 |
| A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation K Och, AT Turki, KM Götz, D Selzer, C Brossette, S Theobald, Y Braun, ... Cancer Medicine 13 (1), e6833, 2024 | | 2024 |
| Motivations for adolescent COVID-19 aaccination FTI Rothoeft, F Brinkmann, C Maier, D Selzer, C Dings, A Kühn, E Möhler, ... | | 2023 |
| Motivations for Adolescent COVID-19 Vaccination: A Comparative Study of Adolescent and Caregiver Perspectives in Germany T Rothoeft, F Brinkmann, C Maier, D Selzer, C Dings, A Kuehn, E Möhler, ... Children 10 (12), 1890, 2023 | 1 | 2023 |
| Physiologically based pharmacokinetic modeling of bergamottin and 6, 7‐dihydroxybergamottin to describe CYP3A4 mediated grapefruit‐drug interactions LM Fuhr, FZ Marok, U Fuhr, D Selzer, T Lehr Clinical Pharmacology & Therapeutics 114 (2), 470-482, 2023 | 4 | 2023 |
| Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network D Feick, S Rüdesheim, FZ Marok, D Selzer, HLH Loer, D Teutonico, ... CPT: Pharmacometrics & Systems Pharmacology 12 (8), 1143-1156, 2023 | 4 | 2023 |
| Modeling of lung-liver interaction during infection in a human microfluidic organ-on-a-chip S Reinhold, C Herr, Y Yao, M Pourrostami, F Ritzmann, T Lehr, D Selzer, ... bioRxiv, 2023.06. 01.543192, 2023 | | 2023 |
| Significant impact of time-of-day variation on metformin pharmacokinetics D Türk, N Scherer, D Selzer, C Dings, N Hanke, R Dallmann, M Schwab, ... Diabetologia 66 (6), 1024-1034, 2023 | 13 | 2023 |
| Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions HLH Loer, D Feick, S Rüdesheim, D Selzer, M Schwab, D Teutonico, ... CPT: Pharmacometrics & Systems Pharmacology 12 (5), 724-738, 2023 | 3 | 2023 |
| A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug–drug interaction perpetrators FZ Marok, JG Wojtyniak, LM Fuhr, D Selzer, M Schwab, J Weiss, ... Pharmaceutics 15 (2), 679, 2023 | 8 | 2023 |
| Prediction of Drug–Drug–Gene Interaction Scenarios of (E)-Clomiphene and Its Metabolites Using Physiologically Based Pharmacokinetic Modeling C Kovar, L Kovar, S Rüdesheim, D Selzer, B Ganchev, P Kröner, S Igel, ... Pharmaceutics 14 (12), 2604, 2022 | 3 | 2022 |
| Pharmacometric modeling of the impact of azelastine nasal spray on SARS-CoV-2 viral load and related symptoms in COVID-19 patients C Dings, P Meiser, F Holzer, M Flegel, D Selzer, E Nagy, R Mösges, ... Pharmaceutics 14 (10), 2059, 2022 | 7 | 2022 |
| Model-based analysis of SARS-CoV-2 infections, hospitalization and outcome in Germany, the federal states and districts C Dings, KM Götz, K Och, I Sihinevich, Q Werthner, S Smola, M Bliem, ... Viruses 14 (10), 2114, 2022 | 8 | 2022 |
| Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates A Sternjakob-Marthaler, B Berkó-Göttel, J Rissland, J Schöpe, E Taurian, ... Plos one 17 (9), e0273332, 2022 | 3 | 2022 |
| Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N1‐Methylnicotinamide: A PBPK Modeling Approach D Türk, F Müller, MF Fromm, D Selzer, R Dallmann, T Lehr Clinical Pharmacology & Therapeutics 112 (3), 687-698, 2022 | 13 | 2022 |
| Physiologically based pharmacokinetic modeling to describe the CYP2D6 activity score-dependent metabolism of paroxetine, atomoxetine and risperidone S Rüdesheim, D Selzer, T Mürdter, S Igel, R Kerb, M Schwab, T Lehr Pharmaceutics 14 (8), 1734, 2022 | 5 | 2022 |
| A physiologically based pharmacokinetic and pharmacodynamic model of the CYP3A4 substrate felodipine for drug–drug interaction modeling LM Fuhr, FZ Marok, M Mees, F Mahfoud, D Selzer, T Lehr Pharmaceutics 14 (7), 1474, 2022 | 7 | 2022 |
Thorsten LehrUniversität des Saarlandes在 mx.uni-saarland.de 的电子邮件经过验证
